By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ProSensa Holding N.V. 

Wassenaarseweg 72

Leiden    2333 AL  The Netherlands
Phone: 31-71-5274202 Fax: 31-71-5274203


SEARCH JOBS


Industry
Biotechnology






Company News
ProSensa Holding N.V. (RNA) Extends The Re-Dosing Of Drisapersen In Europe In Patients With Duchenne Muscular Dystrophy 9/26/2014 7:28:11 AM
ProSensa Holding N.V. (RNA) To Present At Upcoming Conferences 9/25/2014 7:59:11 AM
ProSensa Holding N.V. (RNA) Publishes A Sensitive, Reproducible And Objective Methodology For Dystrophin Analysis In Patients With Duchenne Muscular Dystrophy 9/24/2014 7:38:37 AM
ProSensa Holding N.V. (RNA) Announces Commencement Of Re-Dosing Of Drisapersen In North America In Patients With Duchenne Muscular Dystrophy 9/18/2014 7:52:30 AM
ProSensa Holding N.V. (RNA) Announces 12 Presentations At The 19th International Congress Of The World Muscle Society In Berlin 9/9/2014 10:37:55 AM
ProSensa Holding N.V. (RNA) Announces Lancet Neurology Publication Of An Exploratory Phase 2 Study (DEMAND II) Demonstrating Efficacy And Safety Of Drisapersen In Patients With Duchenne Muscular Dystrophy 9/8/2014 7:15:15 AM
ProSensa Holding N.V. (RNA) Announces 2nd Quarter 2014 Financial Results And Recent Corporate Developments 8/12/2014 8:06:39 AM
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/11/2014 4:28:22 PM
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results And Corporate Update On August 12, 2014 8/4/2014 9:40:08 AM
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014 1:35:19 PM
1234567
//-->